Is a complete ALLR research report available?

No complete published report is available for Allarity Therapeutics, Inc. (ALLR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · USD

$0.96

+0.04 (+4.3%)· Recorded snapshot

Market cap	15.3M
Revenue (ttm)	345K
Net income (ttm)	-12.3M
EPS (ttm)	-$0.79
Shares out	15.9M
Volume	68,557
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 345K
Net income (ttm): -12.3M
EPS (ttm): -$0.79
Market cap: 15.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001860657
Company name	Allarity Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	016744500
Earnings date	2026-11-13
Earnings time	bmo
Employees	8
Employees change	1
Employees growth	14.29%
Enterprise value	$20.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2004
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US0167445008
Last 10-K release date	2026-03-30
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2024-09-11
Last stock split type	Reverse
Market cap	$15.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$0.96
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ALLR
U.S. state	Florida
Website	https://www.allarity.com

Metric

Value

Amount currency

USD

CIK code

0001860657

Company name

Allarity Therapeutics, Inc.

Country

United States

Country code

CUSIP number

016744500

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

Employees growth

14.29%

Enterprise value

$20.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2004

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US0167445008

Last 10-K release date

2026-03-30

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2024-09-11

Last stock split type

Reverse

Market cap

$15.3M

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Price

$0.96

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ALLR

U.S. state

Florida

Website

https://www.allarity.com

Metric	Value
Earnings yield	-82.03%
EV/Sales	57.8x
FCF / EV yield	-69.11%
FCF yield	-94.15%
P/B ratio	4.14x
P/S ratio	42.43x
Price / tangible book value	4.14x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-82.03%

EV/Sales

57.8x

FCF / EV yield

-69.11%

FCF yield

-94.15%

P/B ratio

4.14x

P/S ratio

42.43x

Price / tangible book value

4.14x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	100%
Operating margin	-3,128.99%
Pretax margin	-3,575.07%
Profit per employee	$-1.5M
Revenue per employee	$43,125
ROA	-25.31%
ROA (5Y)	-51.2%
ROCE	-305.29%
ROE	-157.09%
ROIC	-34.28%
SBC / revenue	225.22%

Metric

Value

Gross margin

100%

Operating margin

-3,128.99%

Pretax margin

-3,575.07%

Profit per employee

$-1.5M

Revenue per employee

$43,125

ROA

-25.31%

ROA (5Y)

-51.2%

ROCE

-305.29%

ROE

-157.09%

ROIC

-34.28%

SBC / revenue

225.22%

Metric	Value
EPS growth years	4
Net income growth years	1
Revenue growth 10Y	-4.3%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth 10Y

-4.3%

Revenue growth years

Metric	Value
Capital expenditures	$-72,000
Depreciation and amortization	$-6,000
EBIT	$-10.8M
EBITDA	$-10.8M
EPS	$-0.79
FCF per share	$-0.87
Financing cash flow	$21.8M
Free cash flow	$-13.8M
Free cash flow minus SBC	$-14.6M
Gross profit	$345,000
Investing cash flow	$-72,000
Net borrowing	$20M
Net cash flow	$9.2M
Net income	$-12.3M
Operating cash flow minus SBC	$-14.5M
Operating income	$-10.8M
Revenue	$345,000
Stock-based compensation	$777,000

Metric

Value

Capital expenditures

$-72,000

Depreciation and amortization

$-6,000

EBIT

$-10.8M

EBITDA

$-10.8M

EPS

$-0.79

FCF per share

$-0.87

Financing cash flow

$21.8M

Free cash flow

$-13.8M

Free cash flow minus SBC

$-14.6M

Gross profit

$345,000

Investing cash flow

$-72,000

Net borrowing

$20M

Net cash flow

$9.2M

Net income

$-12.3M

Operating cash flow minus SBC

$-14.5M

Operating income

$-10.8M

Revenue

$345,000

Stock-based compensation

$777,000

Metric	Value
Altman Z-Score	-6.52
Book value per share	$0.22
Debt / equity	6.3
Interest coverage	-10.15
Long-term assets	$386,000
Long-term liabilities	$0
Net cash (debt)	$-5.3M
Net cash / market cap	-36.23%
Net debt / equity	1.5
Piotroski F-Score	0
Property, plant and equipment	$386,000
Shareholders' equity	$3.5M
Tangible book value	$3.5M
Tangible book value per share	$0.22
Total assets	$32.1M
Total cash	$17M
Total debt	$22.3M
Total liabilities	$28.6M
WACC	5.21%

Metric

Value

Altman Z-Score

-6.52

Book value per share

$0.22

Debt / equity

6.3

Interest coverage

-10.15

Long-term assets

$386,000

Long-term liabilities

Net cash (debt)

$-5.3M

Net cash / market cap

-36.23%

Net debt / equity

1.5

Piotroski F-Score

Property, plant and equipment

$386,000

Shareholders' equity

$3.5M

Tangible book value

$3.5M

Tangible book value per share

$0.22

Total assets

$32.1M

Total cash

$17M

Total debt

$22.3M

Total liabilities

$28.6M

WACC

5.21%

Metric	Value
Asset turnover	0.01
Current assets	$31.7M
Current liabilities	$28.6M
Current ratio	1.11
Net working capital	$8.5M
Quick ratio	0.64
Working capital	$3.2M
Working capital turnover	0.05

Metric

Value

Asset turnover

0.01

Current assets

$31.7M

Current liabilities

$28.6M

Current ratio

1.11

Net working capital

$8.5M

Quick ratio

0.64

Working capital

$3.2M

Working capital turnover

0.05

Metric	Value
Buyback yield / dilution	-92.11%
Dividend yield	0%
Shareholder yield	-92.11%

Metric

Value

Buyback yield / dilution

-92.11%

Dividend yield

Shareholder yield

-92.11%

Metric	Value
150-day SMA	$1.27
1D price change	4.28%
1M price change	-6.85%
1M total return	-6.85%
1W price change	9.55%
1W total return	9.55%
1Y price change	-28.4%
1Y return CAGR	-28.42%
1Y total return	-28.4%
20-day SMA	$0.92
200-day SMA	$1.22
3M price change	-22%
3M total return	-22%
3Y price change	-99.73%
3Y return CAGR	-86.12%
3Y total return	-99.73%
50-day SMA	$1.12
50-day SMA vs 200-day SMA	50under200
52-week high	$1.84
52-week high date	2026-05-27
52-week low	$0.77
52-week low date	2026-02-03
6M price change	-29.97%
6M total return	-29.97%
All-time high	$15,287,694.25
All-time high date	2021-12-21
All-time low	$0.61
All-time low date	2025-04-09
Average true range (ATR)	$0.07
Average volume	118.5K
Beta (1Y)	2.08
Beta (2Y)	0.93
Beta (5Y)	0.57
Change from 52-week high	-47.86%
Change from 52-week low	24.81%
Change from all-time high	-100%
Change from all-time low	56.3%
Change from open	4.28%
Day's gap	0%
Dollar volume	$65,774
High price	$0.96
Low price	$0.92
Monthly RSI	9.82
Open price	$0.92
Position in 52-week range	100%
Premarket change	-1.09%
Premarket close	$0.92
Premarket price	$0.91
Premarket volume	3.1K
Previous close	$0.92
Price vs 150-day SMA	-24.63%
Price vs 20-day SMA	3.79%
Price vs 200-day SMA	-21.43%
Price vs 50-day SMA	-14.19%
Relative volume	0.58
RSI	48.5
Sharpe ratio	-0.1
Sharpe ratio (3Y)	-1.49
Sortino ratio	-0.08
Sortino ratio (3Y)	-1.98
Volume	68.6K
Weekly RSI	28.88
YTD price change	-11.17%
YTD total return	-11.17%

Metric

Value

150-day SMA

$1.27

1D price change

4.28%

1M price change

-6.85%

1M total return

-6.85%

1W price change

9.55%

1W total return

9.55%

1Y price change

-28.4%

1Y return CAGR

-28.42%

1Y total return

-28.4%

20-day SMA

$0.92

200-day SMA

$1.22

3M price change

-22%

3M total return

-22%

3Y price change

-99.73%

3Y return CAGR

-86.12%

3Y total return

-99.73%

50-day SMA

$1.12

50-day SMA vs 200-day SMA

50under200

52-week high

$1.84

52-week high date

2026-05-27

52-week low

$0.77

52-week low date

2026-02-03

6M price change

-29.97%

6M total return

-29.97%

All-time high

$15,287,694.25

All-time high date

2021-12-21

All-time low

$0.61

All-time low date

2025-04-09

Average true range (ATR)

$0.07

Average volume

118.5K

Beta (1Y)

2.08

Beta (2Y)

0.93

Beta (5Y)

0.57

Change from 52-week high

-47.86%

Change from 52-week low

24.81%

Change from all-time high

-100%

Change from all-time low

56.3%

Change from open

4.28%

Day's gap

Dollar volume

$65,774

High price

$0.96

Low price

$0.92

Monthly RSI

9.82

Open price

$0.92

Position in 52-week range

100%

Premarket change

-1.09%

Premarket close

$0.92

Premarket price

$0.91

Premarket volume

3.1K

Previous close

$0.92

Price vs 150-day SMA

-24.63%

Price vs 20-day SMA

3.79%

Price vs 200-day SMA

-21.43%

Price vs 50-day SMA

-14.19%

Relative volume

0.58

RSI

48.5

Sharpe ratio

-0.1

Sharpe ratio (3Y)

-1.49

Sortino ratio

-0.08

Sortino ratio (3Y)

-1.98

Volume

68.6K

Weekly RSI

28.88

YTD price change

-11.17%

YTD total return

-11.17%

Metric	Value
Float	15.8M
Float percentage	99.34%
Shares change (QoQ)	-0.36%
Shares change (YoY)	92.11%
Shares held by insiders	0.66%
Shares held by institutions	8.05%
Shares outstanding	15.9M
Short % of float	0.75%
Short % of shares	0.75%
Short ratio	0.9 days

Metric

Value

Float

15.8M

Float percentage

99.34%

Shares change (QoQ)

-0.36%

Shares change (YoY)

92.11%

Shares held by insiders

0.66%

Shares held by institutions

8.05%

Shares outstanding

15.9M

Short % of float

0.75%

Short % of shares

0.75%

Short ratio

0.9 days

Allarity Therapeutics, Inc. (ALLR)

Price

Financial snapshot

Fair-value bridge

Latest news · ALLR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALLR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ALLR

Frequently asked questions